Put simply, it works by signaling your brain that youre not hungry, similar to the bodys natural fight or flight response
Clinical trials showed that the medications were both safe and effective and helped people lose significant percentages of their body weight
By addressing these metabolic disturbances, GLP-1 agonists may create a more favourable environment for mental wellbeing
However, significant weight losswhich these medications facilitatecan naturally improve testosterone levels in men who were previously overweight, potentially reducing your need for replacement therapy over time
Validating urine-based biomarkers (e.g., glomerular cell-derived exosomal ferroptosis regulators, and 4-HNE metabolites) or circulating signatures that correlate with IgA nephropathy disease activity, pathological severity, or response to interventions is urgently needed to guide clinical trial design and patient stratification